- Home
- OBIO vs PROF Comparison
OBIO vs PROF Comparison
Compare OBIO & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- PROF
- Stock Information
- Founded
- OBIO 2017
- PROF N/A
- Country
- OBIO United States
- PROF Canada
- Employees
- OBIO N/A
- PROF N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- PROF Medical/Dental Instruments
- Sector
- OBIO Health Care
- PROF Health Care
- Exchange
- OBIO Nasdaq
- PROF Nasdaq
- Market Cap
- OBIO 151.3M
- PROF 149.7M
- IPO Year
- OBIO N/A
- PROF N/A
- Fundamental
- Price
- OBIO $2.85
- PROF $5.27
- Analyst Decision
- OBIO Strong Buy
- PROF Strong Buy
- Analyst Count
- OBIO 5
- PROF 2
- Target Price
- OBIO $14.20
- PROF $11.50
- AVG Volume (30 Days)
- OBIO 193.1K
- PROF 84.1K
- Earning Date
- OBIO 05-12-2025
- PROF 05-08-2025
- Dividend Yield
- OBIO N/A
- PROF N/A
- EPS Growth
- OBIO N/A
- PROF N/A
- EPS
- OBIO N/A
- PROF N/A
- Revenue
- OBIO $2,886,000.00
- PROF $11,862,000.00
- Revenue This Year
- OBIO $21.38
- PROF $71.17
- Revenue Next Year
- OBIO $31.89
- PROF $134.25
- P/E Ratio
- OBIO N/A
- PROF N/A
- Revenue Growth
- OBIO 30.23
- PROF 75.01
- 52 Week Low
- OBIO $2.37
- PROF $3.90
- 52 Week High
- OBIO $8.87
- PROF $11.42
- Technical
- Relative Strength Index (RSI)
- OBIO 49.08
- PROF 56.43
- Support Level
- OBIO $2.61
- PROF $5.11
- Resistance Level
- OBIO $3.02
- PROF $5.38
- Average True Range (ATR)
- OBIO 0.18
- PROF 0.34
- MACD
- OBIO 0.04
- PROF 0.10
- Stochastic Oscillator
- OBIO 60.19
- PROF 87.93
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.